These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 38289825)
1. Making Sense of Psychedelics in the CNS. Fordyce BA; Roth BL Int J Neuropsychopharmacol; 2024 Feb; 27(2):. PubMed ID: 38289825 [TBL] [Abstract][Full Text] [Related]
2. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Johnson MW; Hendricks PS; Barrett FS; Griffiths RR Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880 [TBL] [Abstract][Full Text] [Related]
4. Molecular targets of psychedelic-induced plasticity. Jaster AM; de la Fuente Revenga M; González-Maeso J J Neurochem; 2022 Jul; 162(1):80-88. PubMed ID: 34741320 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics. Jaster AM; González-Maeso J Mol Psychiatry; 2023 Sep; 28(9):3595-3612. PubMed ID: 37759040 [TBL] [Abstract][Full Text] [Related]
6. The renaissance in psychedelic research: What do preclinical models have to offer. Murnane KS Prog Brain Res; 2018; 242():25-67. PubMed ID: 30471682 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic mechanisms of psychedelics and entactogens. Heifets BD; Olson DE Neuropsychopharmacology; 2024 Jan; 49(1):104-118. PubMed ID: 37488282 [TBL] [Abstract][Full Text] [Related]
9. Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics. Moreton SG; Szalla L; Menzies RE; Arena AF Psychopharmacology (Berl); 2020 Jan; 237(1):21-32. PubMed ID: 31784805 [TBL] [Abstract][Full Text] [Related]
14. Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health. Barnett BS J Psychopharmacol; 2022 Oct; 36(10):1097-1099. PubMed ID: 36112818 [TBL] [Abstract][Full Text] [Related]
16. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry. Barber GS; Dike CC Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705 [TBL] [Abstract][Full Text] [Related]
17. Psychedelics action and schizophrenia. Maćkowiak M Pharmacol Rep; 2023 Dec; 75(6):1350-1361. PubMed ID: 37899392 [TBL] [Abstract][Full Text] [Related]
18. Psychedelics and the essential importance of context. Carhart-Harris RL; Roseman L; Haijen E; Erritzoe D; Watts R; Branchi I; Kaelen M J Psychopharmacol; 2018 Jul; 32(7):725-731. PubMed ID: 29446697 [TBL] [Abstract][Full Text] [Related]
19. Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications. Kraehenmann R Curr Neuropharmacol; 2017; 15(7):1032-1042. PubMed ID: 28625125 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder. Ledwos N; Rodas JD; Husain MI; Feusner JD; Castle DJ J Psychopharmacol; 2023 Jan; 37(1):3-13. PubMed ID: 36515406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]